Neuronal co-expression of EGFP and β-galactosidase in mice causes neuropathology and premature death

Neurobiology of Disease

Volumn 17, Issue 2, 2004, Pages 310-318

  Krestel, Heinz E ^a   Mihaljevic, André L A ^a   Hoffman, Dax A ^b   Schneider, Armin ^c  

^a MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c Axaron Bioscience AG   (Germany)

Author keywords

Cytoplasmic GFP and gal; GCSF and minocycline; Neurogenic paresis; Protein aggregates; Ubiquitin

Indexed keywords

BETA GALACTOSIDASE; ENHANCED GREEN FLUORESCENT PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; MINOCYCLINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEATH; MOTOR CORTEX; MOUSE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PARESIS; PHENOTYPE; PREMATURE DEATH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL;

ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; APOPTOSIS; BETA-GALACTOSIDASE; BRAIN; CELL DIVISION; GRANULOCYTE COLONY-STIMULATING FACTOR; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; MINOCYCLINE; MOTOR CORTEX; MUSCLE WEAKNESS; NERVOUS SYSTEM DISEASES; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; PARESIS; SPINAL CORD; SURVIVAL ANALYSIS; UBIQUITIN;

EID: 5144222230     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.05.012     Document Type: Article

References (30)

1. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., Walter P. Molecular Biology of the Cell. 4th ed.:2002;740-750 Garland Science Publishing (Taylor & Francis Group), New York
2. Baron U., Freundlieb S., Gossen M., Bujard H. Co-regulation of two gene activities by tetracycline via a bi-directional promoter. Nucleic Acids Res. 23:1995;3605-3606
3. Chtarto A., Tenenbaum L., Velu T., Brotchi J., Levivier M., Blum M. Minocycline-induced activation of tetracycline-responsive promoter. Neurosci. Lett. 352:2003;155-158
4. Ciechanover A., Brundin P. The ubiquitin proteasome system in neurodegenerative diseases. Sometimes the chicken, sometimes the egg. Neuron. 40:2003;427-446
5. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev., Neurosci. 2:2001;806-819
6. Crameri A., Whitehorn E.A., Tate E., Stemmer W.P.C. Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat. Biotechnol. 14:1996;315-319
7. Davies S.W., Beardsall K., Turmaine M., DiFiglia M., Aronin N., Bates G.P. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet. 351:1998;131-133
8. De Giorgi F., Brini M., Bastianutto C., Marsault R., Montero M., Pizzo P., Rossi R., Rizzuto R. Targeting aequorin and green fluorescent protein to intracellular organelles. Gene. 173:1996;113-117
9. Detrait E., Bowers W.J., Halterman M.W., Giuliano R.E., Bennice L., Federoff H.J., Richfield E.K. Reporter gene transfer induces apoptosis in primary cortical neurons. Molec. Ther. 5:2002;723-730
10. Felts K., Rogers B., Chen K., Ji H., Sorge J., Vaillancourt P. Recombinant Renilla reniformis GFP displays low toxicity. Strateg. newsl. (Stratagene). 13:2000;85-87
11. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501
12. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 89:1992;5547-5551
13. Hanazono Y., Yu J.M., Dunbar C.E., Emmons R.V. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage. Hum. Gene Ther. 8:1997;1313-1319
14. Heim R., Prasher D.C., Tsien R.Y. Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc. Natl. Acad. Sci. U. S. A. 91:1994;12501-12504
15. Huang W.Y., Aramburu J., Douglas P.S., Izumo S. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat. Med. 6:2000;482-483
16. Hunter A.J., Hatcher J., Virley D., Nelson P., Irving E., Hadingham S.J., Parsons A.A. Functional assessments in mice and rats after focal stroke. Neuropharmacology. 39:2000;806-816
17. Klement I.A., Skinner P.J., Kaytor M.D., Yi H., Hersch S.M., Clark H.B., Zoghbi H.Y., Orr H.T. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 95:1998;41-53
18. Krestel H.E., Mayford M., Seeburg P.H., Sprengel R. A GFP-equipped bidirectional expression module well suited for monitoring tetracycline- regulated gene expression in mouse. Nucleic Acids Res. 29:2001;E39
19. Lamhonwah A.M., Tein I. GFP-human high-affinity carnitine transporter OCTN2 protein: subcellular localization and functional restoration of carnitine uptake in mutant cell lines with the carnitine transporter defect. Biochem. Biophys. Res. Commun. 264:1999;909-914
20. Liu H.S., Jan M.S., Chou C.K., Chen P.H., Ke N.J. Is green fluorescent protein toxic to the living cells? Biochem. Biophys. Res. Commun. 260:1999;712-717
21. Mayford M., Bach M.E., Huang Y.Y., Wang L., Hawkins R.D., Kandel E.R. Control of memory formation through regulated expression of a CaMKII transgene. Science. 274:1996;1678-1683
22. Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407:1997;313-319
23. Rongo C., Kaplan J.M. CaMKII regulates the density of central glutamatergic synapses in vivo. Nature. 402:1999;195-199
24. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62
25. Schabitz W.R., Kollmar R., Schwaninger M., Juettler E., Bardutzky J., Scholzke M.N., Sommer C., Schwab S. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke. 34:2003;745-751
26. Schonig K., Schwenk F., Rajewsky K., Bujard H. Stringent doxycycline dependent control of CRE recombinase in vivo. NAR. 30:2002;e134
27. Yang F., Moss L.G., Phillips G.N. Jr. The molecular structure of green fluorescent protein. Nat. Biotechnol. 14:1996;1246-1251
28. Yuan J., Lipinski M., Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron. 40:2003;401-413
29. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu du C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature. 417:2002;74-78
30. Zolotukhin S., Potter M., Hauswirth W.W., Guy J., Muzyczka N. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70:1996;4646-4654